News
BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes
BD (Becton, Dickinson and Company), a leading global medical technology company, announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus...
News
Regenerative Medicine Market Rapidly Growing Worldwide at Healthy CAGR
As per the Organ Procurement and Transplantation Network, 36,527 organ transplants were accomplished in the United States in 2020. Regenerative medicines plays a vital role...
Clinical Trials
Innovent phase 3 ORIENT-32 trial of Tyvyt in combo with Byvasda to treat advanced hepatocellular carcinoma meets primary endpoints
Innovent Biologics, a biopharmaceutical company, announced the results of a phase 3, open label, randomized study in China. The ORIENT-32 trial evaluating Tyvyt (sintilimab injection)...
News
CPhI Pharma Index: Italy and India the only pharma economies to improve score in 2020
Ahead of the CPhI Festival of Pharma (5-16 October, 2020) – global pharma’s largest ever virtual gathering – the CPhI Pharma Index shows only Italy...
Clinical Trials
Anti-influenza drug Avigan Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients
FUJIFILM Toyama Chemical Co., Ltd. has announced that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” conducted in Japan for...
News
UDG Healthcare Appoints New COO
UDG Healthcare plc, a leading international healthcare services provider, has appointed Ryan Quigley as Chief Operating Officer (COO).
Based in UDG’s headquarters in Dublin, Ireland, Ryan...
News
Sterling Pharma Solutions launches £11 million Material Science Centre
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has officially opened its new multi-million-pound Material Science Centre (MSC), after announcing the investment last...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.